Effectness of Treatment With Mechanical Insufflation-Exsufflation
NCT ID: NCT04149873
Last Updated: 2019-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
240 participants
INTERVENTIONAL
2015-09-30
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Mechanical Insufflation-Exsufflation in Preventing Respiratory Failure After Extubation
NCT01424202
Mechanical Insufflation-Exsufflation in Preventing Post Extubation Respiratory Failure in Patient With Critical Care Neuromyopathy
NCT01931228
Effects of Mechanical Insufflation-Exsufflation With Optimized Settings on Wet Mucus Volume During Invasive Ventilation
NCT06491017
In-line Mechanical Insufflation-Exsufflation in the Management of Ventilated Patients
NCT05365620
Non-invasive Mechanical Ventilation as a Rescue Therapy to Relieve Dyspnea in Patients With Stable Severe COPD
NCT02012101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Traditional chest physiotherapy (CPT) is commonly used to help the critically patients in the effective expulsion of airway secretions. In recent years, new advanced techniques mechanical insufflations-exsufflation (MI-E) and high frequency chest wall oscillation (HFCWO)have been developed to get more effective to remove secretions for patients suffered from acute respiratory failure. The above devices have been described as an effective techniques for patients with chronic neuromuscular weakness, cystic fibrosis and bronchiectasis. By the knowledge, only one study mentioned about MI-E could reduce the reintubation rate and shorten the ICU length of stay. But its limitations include less of case number and not focusing on impaired cough function patients.
In this study, patients defined with impaired cough function as maximum expiratory pressure (MEP) \< 60cmH2O. Collected the patients in our surgical ICU who are able to reach 6-8CC/IBW under pressure support mode for 24 hours and MEP \< 60cmH2O. Then the patients will be allocated to 3 groups to receive (1) conventional CPT (control group) (2) MI-E (study group A) (3) MI-E plus CPT (study group B) until 48 hours after extubation. Reintubation rates, ICU mortality and post-extubation ICU length of stay will be analyzed to evaluate its effects.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Control group' has the treatment with \[Physical chest care \]
MIE
MIE
Experimental group-A
'Experimental group-A' has the treatment with \[Mechanical-Insufflation- Exsufflation\]
MIE
MIE
Experimental group-B
'Experimental group-B' has the treatment with \[Mechanical-Insufflation- Exsufflation\] and \[Physical chest care\]
MIE
MIE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MIE
MIE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2.To be at least 20 years of age.
* 3.To be treated in an ICU at the time of enrollment.
* 4.Endotracheal tube in place
* 5.The patient is mechanically ventilated and reach:
1. Ventialtopr: Pressure support mode
2. reach 6-8CC/IBW, ideal body weight for 24 hours
3. MEP, maximum expiratory pressure \< 60cmH2O
Exclusion Criteria
* 2.\< 20 years of age.
* 3.Neither endotracheal tube nor mechanical ventilator use
* 4.The patient is mechanically ventilated, but:
1. The ventialtopr mode NOT: Pressure support mode
2. No reach 6-8CC/IBW, ideal body weight for 24 hours
3. MEP, maximum expiratory pressure \> 60cmH2O
* 5.Participation as subject in another interventional study within 30 days prior to the first dose of study treatment, or planned participation in such a study during the study or within 30 days of its completion by the patient.
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chimei Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kuo-Chen Cheng
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kuo-Chen Cheng, Chief
Role: STUDY_CHAIR
Chi Mei Medical Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Intensive Care Medicine; Chi Mei Medical Center
Tainan City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMFHR 10460(IRB10407-008)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.